Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Impacts of sulforaphane on proliferation, apoptosis and PI3K/Akt pathway of human colon cancer HT-9 cells
Hits 1544  Download times 1189  Received:May 15, 2018  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2018.10.15
Key Words   sulforaphane;human colon cancer cells;proliferation;apoptosis;mechanism
Author NameAffiliationE-mail
ZHU Tao Department of Gastroenterology, Central Hospital of Enshi Autonomous Prefecture, Enshi 445000, China  
ZHANG Jigui Endoscopy Center, Central Hospital of Enshi Autonomous Prefecture, Ensh 445000, China 303715495@qq.com 
Abstract
    [Objective] To observe the impacts of sulforaphane on proliferation, apoptosis and PI3K/Akt pathway of human colon cancer HT-9 cells.[Methods] The effects of sulforaphane on proliferation of HT-9 cells were investigated using CCK8 assays. The HT-9 cells apoptosis was analyzed by flow cytometry with propidium iodide staining. The expression levels of related proteins in PI3K/Akt pathway and apoptosis proteins were analyzed by Western Blot.[Results] Sulforaphane can significantly suppress proliferation of HT-9 cells in a time-and dose-dependent manner. Propidium iodide staining showed that the apoptosis of HT-9 cells was stimulated by sulforaphane. After treated with 10, 20, 40 μg/mL of sulforaphane for 24 h, the apoptosis rates were (14.67±1.95)%, (27.95±2.53)% and (35.6±3.75)%, respectively. Sulforaphane downregulated the expression levels of PI3K, p-Akt and Bax proteins and upregulated the expression of Bax protein in a dose-dependent manner.[Conclusion] Sulforaphane can significantly suppress the proliferation of HT-9 cells and stimulate apoptosis, the mechanism may be associated with the inhibition of PI3K/Akt signaling pathway.

You are the Guest visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.